Navigation Links
Obesity Hormone -' Leptin' may treat Metabolic Disorder

According to new findings, Leptin- the so-called obesity hormone may help patients in treating a rare disorder marked by a loss of fat tissue and other metabolic abnormalities.The study's author found that the results of this study lays the foundation for research into the role of leptin in common metabolic conditions such as type 2 diabetes. //

Dr. Elif Oral and her colleagues found that a lab-engineered version of leptin, which is usually produced by fat cells, improved several metabolic problems in nine women with lipodystrophy. These patients had little or no fat tissue due to either a genetic defect or an abnormal immune system attack on the body's own tissue.

Along with low blood levels of leptin, the condition is typically marked by high levels of blood fats called triglycerides, resistance to the blood-sugar-regulating hormone insulin, and diabetes. Diabetes occurs when the body loses sensitivity to insulin and blood sugar levels rise out of control. Typically, this rare form of lipodystrophy is treated with a combination of insulin and other diabetes drugs, as well as cholesterol-lowering agents.

But her team found that 4 months of injections with the engineered leptin boosted patients' blood levels of the hormone, cut their triglycerides and improved their blood sugar levels. And during leptin treatment, the women were able to discontinue on their diabetes therapies. The treatment "really made a big impact on their quality of life," said Oral, who was with the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, Maryland, at the time of the study.

According to the team, along with this success in improving the disorder, the study also indicates the importance of body fat and leptin levels in maintaining a normal metabolism, Specifically, adequate leptin levels appear necessary for normal insulin sensitivity.

This would be in addition to its already-recognized job in helping r egulate appetite. Leptin has been called the obesity hormone--and has been mainly studied in this context--because leptin levels rise in proportion to body fat, and obese individuals have been thought to have leptin resistance.

Animal research has suggested that a lack of leptin may be involved in the development of insulin resistance, but this is the first evidence in humans that this may be the case. She said that future research should look into how leptin levels might factor into type 2 diabetes, the common form of diabetes that is closely linked to obesity and is preceded by the development of insulin resistance.

The study was funded by the US National Institutes of Health and the Thousand Oaks, California-based pharmaceutical company Amgen, which supplied the leptin product.


'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... ... New Brunswick, New Jersey: This year marks Children’s Specialized Hospital ’s 125th ... the anniversary, the hospital has themed the milestone “Hats Off” and kicked off the ... on Saturday, May 21, at Johnson Park in Piscataway, New Jersey. , ...
(Date:5/24/2016)... — , ... (PRWEB) ... of three new members of its Advisory Board. Joining the ... Sarah Kusch. “All three of them embody the mission of our ... are very fortunate to have them as we continue to expand ...
(Date:5/24/2016)... ... ... Boyd Industries, a leading supplier of dental chairs and cabinetry , will ... dentistry , at AAPD 2016, the annual conference and trade show of the American ... keeps dental hand pieces and other anxiety-provoking pieces of the dental delivery system out ...
(Date:5/24/2016)... Angeles, CA (PRWEB) , ... May 24, 2016 ... ... to everything egg freezing, today announced the official relaunch of its community and ... use their frozen eggs. Eggsurance's mission is to create a safe and welcoming ...
(Date:5/24/2016)... Maryland (PRWEB) , ... May 24, 2016 , ... ... announced the appointment of Jonathan (Jon) Otterstatter to its board of ... is a proven leader in the development of technological innovations that lead to ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016 ... titled, " Exocrine Pancreatic Insufficiency Market - Global Industry ... 2023 ." According to the report, the exocrine pancreatic ... of 8.3% from 2015 to 2023 to reach US$2.85 ... is a condition characterized by the deficiency of the ...
(Date:5/23/2016)... -- The World Health Organization (WHO) expanded the Intended Use ... aged 13 years, and above. Effective immediately, the PrePex device, ... adolescent males in the 14 priority countries in Southern and ... male circumcision device to receive WHO Prequalification on 31 May ... said: " The expanded use of PrePex for ...
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
Breaking Medicine Technology: